Morrison & Foerster’s ‘dedicated' practice handles a broad range of transactional issues within the technology sector, in addition to e-commerce, biotech, and online gaming. Thomas Chou is particularly active on transactions within the TMT and life sciences spaces, while Marcia Ellis maintains a private equity focused practice and regularly assists SPACs. Maureen Ho has broad experience in leveraged buy-outs, joint ventures, and bolt-on acquisitions. Vivian Yiu frequently acts for both state owned and private Chinese enterprises in matters involving mandatory cash offers.
Testimonials
Collated independently by Legal 500 research team.
‘They work really hard when dealing with different timezones. Have a good understanding of that are the key issues and able to help negotiate with different parties. Very professional throughout the process.’
‘Professional. Dedicated. Always available and very tactful in dealing with complex issues. Thomas Chou is a great leader.’
Key clients
- Alibaba Group
- Arm Limited
- GLP
- Jamieson Wellness
- Softbank
- Softbank Vision Fund
- Silver Crest
Work highlights
- Advised SoftBank Group Corp. and SoftBank Vision Fund on their acquisition of a substantial interest in Arm China, as a necessary step enabling the planned listing of Arm Limited.
- Advised Alibaba Group Holding Limited in the renegotiation and amendment of various agreements between AGH and Ant Group Co., Ltd. related to AGH’s acquisition of a 33% stake in Ant, China’s leading financial services and technology company.
- Advised Amperex Technology Limited in its RMB14 bn joint ventures for mid-size battery cells and packs and US$1.5 bn technology cross-license arrangement with Contemporary Amperex Technology Co., Limited.
Practice head
The lawyer(s) leading their teams.
Thomas Chou, Marcia Ellis, Maureen Ho, Paul McKenzie, Chuan Sun, Vivian Yiu